Vysov-M 50/500 mg (Vildagliptin/Metformin)
| Active Ingredient | Vildagliptin/Metformin |
|---|---|
| Indication: | Type 2 diabetes |
| Manufacturer: | Cipla Limited |
| Strength | 50mg/500mg |
| Packaging | 15 Tablets in 1 strip |
| Delivery Time | 6 To 15 days |
Vysov-M 50/500 mg is a powerful combination of Vildagliptin and Metformin, designed for the effective management of type 2 diabetes mellitus. Vildagliptin, a DPP-4 inhibitor, enhances the body’s natural ability to regulate blood sugar by increasing the release of insulin and decreasing the production of glucagon. Metformin, a biguanide, works by reducing liver glucose production and improving insulin sensitivity in muscles.
Together, this dual-action therapy helps in achieving better glycemic control, especially in patients not adequately managed with Metformin alone. Vysov-M 50/500 mg is usually taken with meals to reduce gastrointestinal discomfort. Regular use, along with lifestyle modifications such as a healthy diet and exercise, can significantly improve blood sugar levels and reduce the risk of diabetes-related complications. Always follow your doctor’s instructions for the correct dosage and monitoring routine for best results.








There are no reviews yet.